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Viral fusionC8, a short peptide characterized by three regularly spaced Trp residues, belongs to the membrane-proximal
external functional domains of the feline immunodeﬁciency virus coat protein gp36. It elicits antiviral activity
as a result of blocking cell entry and exhibits membranotropic and fusogenic activities. Membrane-proximal ex-
ternal functional domains of virus coat proteins are potential targets in the development of new anti-HIV drugs
that overcome the limitations of the current anti-retroviral therapy. In the present work, we studied the confor-
mation of C8 and its interaction with micellar surfaces using circular dichroism, nuclear magnetic resonance and
ﬂuorescence spectroscopy. The experimental data were integrated by molecular dynamics simulations in a mi-
celle–water system. Our data provide insight into the environmental conditions related to the presence of the
fusogenic peptide C8 on zwitterionic or negatively charged membranes. The membrane charge modulates the
conformational features of C8. A zwitterionicmembrane surface induces C8 to assume canonical secondary struc-
tures, with hydrophobic interactions between the Trp residues and the phospholipid chains of the micelles. A
negatively charged membrane surface favors disordered C8 conformations and unspeciﬁc superﬁcial interac-
tions, resulting in membrane destabilization.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Human immunodeﬁciency virus (HIV) enters the target cell using
fusion machinery composed of the non-covalently associated gp120
and gp41 glycoproteins. The formation of the fusion complex induces
extensive conformational changes in gp120, resulting in thedissociation
of the gp120/gp41 complex and the subsequent release of metastable
gp41. Virus–cell fusion is then initiated by the gp41 ectodomain [1].
The gp41 ectodomain contains several characteristic functional do-
mains, including the fusion peptide (FP), N-terminal heptad repeat
(NHR), C-terminal heptad repeat (CHR) andmembrane proximal extra-
cellular region (MPER). TheMPER is located at the C-terminal end of the
HIV-1 gp41 ectodomain and is directly followed by the transmembrane
domain. In the HIV-1 gp41 pre-hairpin structure, the MPER and the
FP are the functional links by which the gp41 pre-hairpin bridges the
viral and target cell membranes through the formation of a coiled-coil
six-helix bundle (6HB) structure [2].
Fusion inhibitors that target gp41's functional domains to prevent
6HB formation and terminate the HIV-1-cell fusion process can be used
as drugs to prevent HIV-1 infection.cy, University of Salerno, Via
969748.
ights reserved.In 2003, a 36-amino acid peptide derived from the CHR of the HIV-1
gp41 ectodomain (enfuvirtide T20) was approved by the US FDA for
anti-HIV treatment. T20 is the only currently approved drug targeting
gp41; however, thehigh cost and inconvenience of the twice daily injec-
tion of this peptide drug prevent it frombeing used as a regular anti-HIV
drug [3]. The development of new fusion inhibitors that overcome the
limitations of T20 is of great importance. The NHR and CHR are still the
most intensively investigated targets in gp41 [4]. Other less exploited
functional domains, such as the FP [5] and the MPER [6], are receiving
increasing attention as potential targets for fusion inhibitors.
Feline immunodeﬁciency virus (FIV) is a naturally occurring lentivi-
rus [7] that is studied as a model system for anti-HIV vaccines and anti-
HIV drug development [8,9]. In a manner analogous to that for HIV, FIV
enters cells via a mechanism involving a surface glycoprotein named
gp36 [10–12]. Gp36 has a structural architecture similar to that of
gp41. The MPER of gp36 has a crucial role in the membrane fusion pro-
cess [7,13–15]. We previously demonstrated that several short synthet-
ic peptides that mimic the MPER of gp36 [16,17] reduce the infectivity
of FIV [18]. In particular, the fragment 770WEDWVGWI776, dubbed C8,
elicited antiviral activity as a result of blocking cell entry, as observed
for HIV fusion inhibitors [19,20]. A structure–activity-relationship
(SAR) study and preliminary nuclear magnetic resonance (NMR) con-
formational analysis demonstrated that C8's antiviral activity depends
on thepresence of regularly spaced Trp residues and that the orientation
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tions [21–25].
The antiviral activity based on blocking cell entry strongly supports
the hypothesis that C8 has a direct interaction with the virus or the
cell membrane; therefore, understanding these interactions may pro-
vide new insight into the mechanism of virus–cell fusion and may aid
in the identiﬁcation of new targets for FIV and HIV fusion inhibitors.
With this in mind and given the hypothesis that the membrane's prop-
erties have profound effects on the fusion processes involving the FIV-1
gp36 ectodomain and beyond, C8 has been studied in membrane
models of varying complexity and compositions using several spectro-
scopic techniques and molecular dynamics simulations [26,27]. Our
data show that C8 adsorbs strongly to zwitterionic bilayer surfaces
due to hydrogen bonds and hydrophobic interactions involving the
Trp side chains and the lipid head groups. This interaction induces
a decrease in the bilayer thickness and an increase in the hydration
of the lipid head groups [28]. In dipalmitoylphosphatidylcholine
(DPPC) bilayers containing cholesterol and sphingomyelin, the peptide-
induced fusionmechanism requires a strict interplay among the different
lipids [29].
The reported data, although acquired in highly sophisticated bio-
membrane environments, present only indirect information about
C8's three-dimensional structure. Therefore, to develop a structural
model of C8 in membrane mimetic conditions, in the present work we
performed a conformational analysis using circular dichroism (CD)
and NMR in micelle solutions of dodecylphosphocholine (DPC) and
sodium dodecyl sulfate (SDS) detergents; these are accepted mimetics
of negatively charged and zwitterionic bio-membranes respectively,
suitable for NMR spectroscopy [30,31]. To study the positioning of C8
on the micelle surface, we used ﬂuorescence spectroscopy, pulsed
ﬁeld gradient (PFG) NMR experiments and NMR measurements in the
presence of spin labels. The experimental data were integrated by
molecular dynamics calculations in a micelle–water system.
Our data show that membrane charge modulates the conformation
of C8. Zwitterionic membrane surfaces induce a regular C8 conforma-
tion, with hydrophobic interactions occurring between Trp residues
and the phospholipid chains. Negative charges favor C8 conformational
ﬂexibility and superﬁcial interactions resulting in membrane destabili-
zation. Information concerning the conformational preferences of C8
and its mode of interactions with micelle surfaces may be used in the
design of new fusion inhibitors targeting the MPER.
2. Experimental section
2.1. Peptide synthesis
C8 peptide was preparedmanually using a conventional solid-phase
strategywithN-α-ﬂuorenylmethoxycarbonyl-protected amino acids and
a Rink-amide resin as a solid support. The peptidewas N-terminally acet-
ylated and C-terminally amidated to improve enzymatic stability. The
crude peptide was puriﬁed to homogeneity by semipreparative reverse-
phase high-pressure liquid chromatography, resulting in a purity greater
than 95%, and then lyophilized. The ﬁnal product was characterized by
analytical high-pressure liquid chromatography and electrospray mass
spectrometry [18].
2.2. Fluorescence spectroscopy
Fluorescence measurements were performed at 300 K using a LS55
Luminescence Spectroﬂuorimeter (Perkin Elmer). The excitation wave-
length was 280 nm, and emission spectra were recorded between 310
and 450 nm with an excitation slit width of 5 nm, an emission slit
width of 2.5 nm and a scan speed 50 nm/min. The titrations with SDS
and DPC were performed by adding known amounts of a phosphate
buffer solution (pH 7; 10 mM) containing the peptide (3 × 10−6 M)
and the surfactant at a concentration well above the critical micelleconcentration (c.m.c.) to a weighed amount of a phosphate buffer solu-
tion of the peptide with the same concentration, initially placed into
the spectroﬂuorimetric cuvette. In this manner, the surfactant concen-
tration was progressively increased while the peptide concentration
remained constant during the whole titration. After each addition,
there was a 10-min wait to ensure that equilibrium had been reached.
2.3. Circular dichroism spectroscopy
All CD spectra were recorded using a JASCO J810 spectropolarimeter
at room temperature with a cell path length of 1 mm. CD spectra were
acquired at 25 °C using a measurement range from 190 to 260 nm, a
bandwidth of 1 nm, four accumulations and a scanning speed of
10 nm/min. During all the measurements, the trace of the high tension
voltage was veriﬁed to be less than 700 V, which should ensure the re-
liability of the data obtained [32]. Spectra were corrected for the solvent
contribution.
Samples containing the peptide (1 × 10−4 M) in phosphate buffer
(pH 6.8, 25 mM) and increasing concentrations of DPC (0.6 mM,
1.2 mM, 5.0 mM and 10 mM) or SDS (4.0 mM, 8.0 mM, 40 mM and
80 mM) were prepared. Estimation of secondary structure content
was performed using the algorithms CONTIN and SELCON from the
DICHROWEB website [33].
2.4. NMR analysis
Samples for NMR experiments were prepared to have C8 1 mM, in
mixture of DPC- or SDS-aqueous solution (pH 6.8 phosphate buffer con-
taining H2O/D2O 90:10 v/v). C8 phosphate buffer solution was titrated
with increasing amounts of d25-SDS (4.0 mM, 8.0 mM, 40 mM and
80 mM) or d38-DPC (0.6 mM, 1.2 mM, 5.0 mM and 10 mM) surfactant.
1D 1H homonuclear spectra in the Fouriermodewith quadrature detec-
tion were recorded at each step of the titration. Two-dimensional (2D)
1H homonuclear TOCSY and NOESY spectra were recorded in the ﬁnal
micelle solutions containing 1.0 mM C8 and 10.0 mM DPC or 80.0 mM
SDS respectively.
NMR spectra were recorded on a Bruker DRX-600 spectrometer. 2D
1H homonuclear TOCSY andNOESY spectrawere collected in the phase-
sensitive mode using quadrature detection in ω1 by time-proportional
phase incrementation of the initial pulse [34–36]. The water signal
was suppressed using WATERGATE pulse sequence experiments [37].
The data block sizes were 2048 addresses in t2 and 512 equidistant t1
values. Before Fourier transformation, the time domain data matrices
were multiplied by shifted sin2 functions in both dimensions. A mixing
timeof 70 mswasused for the TOCSY experiments. NOESY experiments
were run at 300 K with mixing times in the range of 100–300 ms.
Qualitative and quantitative analyses of DQF-COSY, TOCSY, and NOESY
spectra were performed using SPARKY software [38].
NMR experiments in the presence of spin-probes were performed
using a solution of 5-DSA spin-probes prepared using methanol-d4
as the solvent. The spin-probes were added to deuterated SDS-d25
and DPC-d38 micellar solutions of C8 peptides at a spin-probe/micelle
concentration ratio of 1:1.
2.5. NMR structure calculations
Peak volumes were translated into upper distance bounds with
the CALIBA routine from the CYANA software package [39]. The requi-
site pseudoatom corrections were applied for non-stereospeciﬁcally
assigned protons at pro-chiral centers and for the methyl group. After
discarding redundant and duplicated constraints, the ﬁnal list of exper-
imental constraints was used to generate an ensemble of 100 structures
with the standard CYANA protocol of simulated annealing in the torsion
angle space (using 10,000 steps). No dihedral angle or hydrogen bond
restraints were applied. The best 20 structures that had low target
function values and small residual violations were reﬁned by in vacuo
Fig. 1.Normalized circular dichroism spectra of C8 inphosphate buffer and in the presence
of increasing concentrations of DPC (A) and SDS (B).
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of the AMBER 5.0 suite [40,41]. To mimic the effect of solvent screening,
all net charges were reduced to 20% of their real values. In addition, a
distance-dependent dielectric constant (ε = r) was used. The cut-off
for non-bonded interactions was 12 Å. NMR-derived upper bounds
were imposed as semi-parabolic penalty functions, with force constants
of 16 kcal/mol Å2. The function was shifted to be linear when the viola-
tion exceeded 0.5 Å. The best 10 structures after minimization had
AMBER energies ranging from−1541.4 to−1391.1 kcal/mol. The ﬁnal
structures were analyzed using the Insight 98.0 program (Molecular
Simulations, San Diego, CA, USA).
2.6. PFG-NMR measurements of diffusion
Diffusion NMR measurements were performed using the PFG meth-
od on aBrukerDRX500 spectrometer equippedwith a z-gradient system
capable of producing magnetic ﬁeld pulse gradients of approximately
50 G cm−1 using a 5 mm inverse BBI probe. The bipolar phase longitudi-
nal encode decode (BPP-LED) sequence developed by Johnson and
coworkers [42,43] was used to determine the self-diffusion coefﬁcient
of C8 (i) in aqueous solution and (ii) in SDS or DPC micellar solutions.
The surfactants' self-diffusion coefﬁcients were also determined in the
absence and the presence of the peptide. For each investigated sample,
a series of twenty BPP-LED experiments was conducted with increasing
gradient strength. The intensity of the observed signal is related to diffu-
sion by
Ii ¼ I0i exp −Diγ2g2δ2 Δ−δ=3ð Þ
h i
ð1Þ
where Ii is the intensity of the ith signal in the presence of the gradient
pulses; I0i is the intensity of the ith signal without the gradient pulses;
γ is the magnetogyric ratio of the observed nucleus; δ and g are the
gradient duration and strength, respectively; Δ is the distance between
the leading edges of the gradient pulses (the diffusion time); and Di is
the diffusion coefﬁcient of the ith species [42,44–46].
To determine Ii, each spectrum was integrated in a speciﬁc region
that contained no overlapping signals. Accurate values of the diffusion
coefﬁcients were obtained by ﬁtting the plot of the normalized attenu-
ated signals vs. the term γ2g2δ2(Δ − δ/3) to a mono-exponential
function.
2.7. Molecular dynamics simulation
The starting coordinates of the DPCmicelle–water complexwere ex-
tracted from simulations performed byWymore andGao [47]. Similarly,
the initial coordinates of the SDS micelle–water complex were taken
from molecular dynamics (MD) simulations performed by MacKerell
[48]. The solved NMR structures of C8 in SDS and DPCmicelle solutions
were used as the starting conformations for the molecular dynamics
simulations.
DPCmicelles aremade up of 65molecules of DPCwith a total charge
of 0. The simulation box dimensions were X = 65.26 Å, Y = 65.26 Å,
and Z = 65.26 Å. A total of 7752 molecules of water, 28 Cl− ions and
30 Na+ ions were added to reach the density of 0.997 g/mL and physi-
ological osmolarity [47]. The peptide's formal charge is−2.
SDSmicelles are made up of 60molecules of SDS with a total formal
charge of −60. The simulation box dimensions were X = 70.37 Å,
Y = 70.37 Å, and Z = 70.37 Å. A total of 12,560 molecules of water,
12 Cl− ions and 74 Na+ ions were added to reach the density of
0.997 g/mL and physiological osmolarity [48].
To generate the initial structure, we applied two different methods:
the ﬁrst method consisted of placing the peptide in the center of the
micelle with the two centers of mass overlapping, as described by
Kaznessis [49]. To minimize the bumps, the peptide was reduced tohalf of its size, and the intramolecular forces were scaled down to 10%
of the initial values. The system was annealed while the forces were
brought back to standard values.
The second method, which we have successfully applied in the
past [50,51], consisted of generating hundreds of initial poses in which
the peptide's barycenter and orientation are randomly chosen. The
conﬁgurations were distributed into a newly developed grid [www.
yadamp.unisa.it/grimd] to obtain the best starting conﬁguration. The
two methods converged into the same initial conﬁguration.
Molecular dynamics simulations were performed using YASARA
12.7.16 [52] with the NPT ensemble at 310 K and 1 atm by coupling
the system with a Berendsen thermostat [53] and by controlling the
pressure in the manometer pressure control mode. The YAMBER3
force ﬁeld was used. All simulations ran with a 1.25 fs time step for
intramolecular forces and a 2.50 fs time step for intermolecular forces.
The equilibration period was 20 ns.
The production run for the C8–DPC micelle system lasted 50 ns,
whereas that for the C8–SDS micelles lasted 150 ns.
Fig. 2. NOE connectivities from NOESY spectra of C8 in SDS (A) and DPC (B) micelle solu-
tions. Spectrawere collected at 600 MHz and 300 Kwith the following concentrations: C8
peptide, 1 mM; SDS, 80 mM and DPC, 10 mM.
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3.1. Conformational analysis
3.1.1. CD spectroscopy
The conformation of C8 in DPC and SDSmicelles was analyzed by CD
spectroscopy. CD spectra were recorded in phosphate buffer (pH 6.8),
and phosphate buffer containing increasing amounts of DPC or SDS
(Fig. 1).
Quantitative estimation of C8 CD spectra was performed using
DICHROWEB website. Both CONTIN and SELCON softwares were used
for a validation of the results [33]. CD spectra of C8 recorded at
submicellar concentrations of DPC and SDS detergents respectively indi-
cate the coexistence of equally populated conformer families correspond-
ing to β-strands, β-turns and unordered structures. This conformational
behavior is mainly conserved at micellar and supramicellar SDS concen-
trations. At micellar and supramicellar DPC concentrations CD spectra
of C8 indicate the prevalence of β-turn structure.
3.1.2. NMR analysis
NMR spectra were recorded on a Bruker DRX-600 spectrometer. 1H
monodimensional NMR spectra were recorded in water containingFig. 3. NMR structure bundles for C8 in SDS (A) and DPC (B) micelle soincreasing amounts of detergents. At concentrations of SDS and DPC
tenfold greater than the c.m.c., 2D COSY, TOCSY and NOESY were
recorded to allow chemical shift assignment according to the conven-
tional procedure of Wuthrich [54]. The proton chemical shifts of C8
are reported in the Supplementary data (Tables S1–S2).
Analysis of the chemical shifts revealed signiﬁcant perturbations in
the proton resonances in response to the addition of DPC, whereas
less evident chemical shift modiﬁcations were observed in response to
the addition of SDS.
3.1.3. NMR structure calculation
COSY, TOCSY and NOESY spectra of C8 in DPC and SDSmicelles were
recorded and analyzed using SPARKY software [38]. Fig. 2 shows a sum-
mary of all sequential andmedium-range connectivities observed in the
NOESY spectra of C8 in DPC and SDS micelle solutions. Fig. 2A shows
that minor NOE effects were present in the NOESY spectra of C8 in the
SDS micelle solution, indicating the prevalence of disordered and ﬂexi-
ble conformations. In contrast, Fig. 2B shows that the NMR spectra of C8
in DPC micelles include regular sequential and medium-range NOEs,
consistent with the presence of regular secondary structures.
On the basis of the NOE data, structure calculations for C8 were
performed using CYANA software. The NMR structure bundles (Fig. 3)
revealed the paucity of ordered structures in SDS (RMSD 0.98), whereas
high structural agreement was observed for the NMR structure bundle
of C8 in DPC micelle solution (RMSD C8 in DPC: 0.69). Analysis of the
backbone torsion angles according to PROMOTIF algorithms [55] indi-
cated the preponderance of type I β-turn conformations involving resi-
dues Trp1–Trp4, Glu2–Val5 andVal5–Ile8 inDPCmicelles. In SDSmicelles,
less regular secondary structures were observed, with aminor presence
of γ-turns.
3.2. C8–micelle interactions
3.2.1. Fluorescence titration measurements
Changes in the solvent exposure of the tryptophan residues of C8
due to the peptide's interactionswith SDS or DPCmicelles were studied
by monitoring the Trp ﬂuorescence emission spectra at increasing
surfactant concentrations. The ﬂuorescence intensities of some ﬁne
vibronic structures in the Trp ﬂuorescence spectrum exhibit stronglutions. The structures are overlapped at the level of the backbone.
Table 1
Self-diffusion coefﬁcients (Dobs) and hydrodynamic radii of SDS and DPC micelles in the











C8 in phosphate buffer 2.85 / /
C8 in 10 mM DPC 0.85 0.86 22
C8 in 80 mM SDS 0.80 0.82 24
10 mM DPC / 0.89 21
80 mM SDS / 0.96 20
a Samples were solubilized in 25 mM buffer phosphate at pH 6.8 in D2O at 302 K.
1014 M. Scrima et al. / Biochimica et Biophysica Acta 1838 (2014) 1010–1018environmental dependence [56,57] in particular, the emission maxi-
mum shifts from 355 to 360 to approximately 330 nm when
transitioning from water to an apolar medium. The quantum yield
could also undergo large changes, the direction and extent of which de-
pend on the system under consideration [58–60].
The ﬂuorescence spectra of C8 in phosphate buffer indicate that the
Trp side chains were fully exposed to the aqueous medium (λmax ≈
354 nm). In the presence of DPC micellar aggregates, a dramatic quan-
tum yield increase was observed (Fig. 4B) due to the peptide's inter-
action with the micelles. However, a limited shift in the emission
maximum (λmax ≈ 345 nm) was observed, thus indicating that the
Trp residues of themicelle-interacting peptidemove to an environment
only slightly more apolar than that of the aqueous solution. This evi-
dence suggests that the peptide was positioned at themicelle interface.
To gain quantitative information on the peptide–surfactant interaction,
we analyzed the variation in Trp ﬂuorescence for C8 at λ = 354 nm
with changes in the DPC concentration (Fig. 4B). The C8 spectrum
remained unperturbed up 0.6 mM, corresponding to the surfactant's
c.m.c., indicating an almost negligible interaction between C8 and DPC
monomers. Above the c.m.c., the ﬂuorescence steeply increased, quickly
reaching a plateau value. When a nonlinear best-ﬁtting procedure was
applied to the data according to a previously reported model [26], the
apparent peptide–surfactant association constant, Ka, and the number
of DPCmolecules, n, that bind the peptide can be estimated. The obtain-
ed results (Ka = (1.8 ± 0.3) × 105 M−1, n = 4 ± 1) point to a strong
C8 interactionwith a low number of DPCmolecules. Interestingly, these
values are slightly lower than those obtained for C8 interacting with
POPC liposomes (Ka = (8.3 ± 0.6) × 105 M−1, n = 6 ± 2) [26].
These lower values could be an effect of the higher curvature of the
micelles than the vesicular aggregates.
The ﬂuorescence spectrum of C8 was not signiﬁcantly modiﬁed by
the addition of SDS (Fig. 4A and B), indicating that there was minimal
perturbation of the Trp hydration upon the interaction of C8 with SDS
micelles.3.2.2. NMR diffusion experiments
Self-diffusion coefﬁcients are useful tools for obtaining structural
information aboutmulti-component systems [61,62], as they are closely
related to the hydrodynamic radii of the diffusing particles [63]. The








310 330 350 370 390 410 430 450
C8 in PBS
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Fig. 4. (A) Fluorescence emission spectra of C8 in phosphate buffer and in the presence of DPC a
λ = 354 nmwith increasing DPC or SDS concentrations. The solid line shows the data interpoaggregation phenomena [64,65] and, in micellar solutions, on the inter-
action with the surfactant aggregates [66–69].
In the present study, PFG-NMR experiments were ﬁrst performed
on C8 aqueous solutions. The observed peptide diffusion coefﬁcient,
DC8 = (2.85 ± 0.04) × 10−6 cm2 s−1, was quite high, indicating that
the peptide exhibited no tendency to self-aggregate.
The peptide self-diffusion coefﬁcients in SDS and DPC micelle solu-
tions, DC8(SDS) and DC8(DPC), are shown in Table 1. They were much
lower than that observed in the aqueous solution, suggesting that C8
signiﬁcantly interacted with both micellar systems. Generally speaking,
the self-diffusion coefﬁcient of a peptide in a micellar solution is the
weighted average of the coefﬁcients of the free andmicelle-boundmol-
ecules [66,70] because the free and bound peptides are undergoing fast
exchange on theNMR timescale. The diffusion coefﬁcient of free peptide
molecules can be assumed to be equal to the peptide diffusion coefﬁ-
cient in aqueous solution after correction for the obstruction of diffusion
by the micellar aggregates [66]. In contrast, the diffusion coefﬁcient
of the bound peptides coincides with the diffusion coefﬁcient of the
micelles, provided that the concentration of themicelles is much higher
than the c.m.c. for the particular surfactant [66,71], which is the case for
this study. The diffusion coefﬁcient/s of the surfactants in the presence
of the peptide, DSDS(C8) andDDPC(C8), are also reported in Table 1. Inspec-
tion of the table shows that DC8(SDS) and DC8(DPC) coincided, within the
experimental uncertainty, with DSDS(C8) and DDPC(C8). In other words,
the peptide molecules diffused together with the surfactant aggregates,
and the fraction of free C8 was negligible.
For comparison, measurements were performed on SDS–water and
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nd SDS at the concentrations indicated in the legend. (B) Trp ﬂuorescence variation of C8 at
lation according to the model cited in the text.
Fig. 5. 1H backbone NH intensities of C8 in DPC and SDS micelles recorded in the absence
and the presence of 5-doxyl-stearic acid. Legends in the frames are relative to spin label
concentrations.
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coefﬁcients obtained in the absence of the peptide, DSDS and DDPC, are
shown in Table 1.
Interestingly, DSDS(C8) and DDPC(C8) were lower than DSDS and DDPC.
The reduction in the self-diffusion coefﬁcient of DPCwas small, whereas
this decrease is signiﬁcant in the case of SDS. The surfactant self-
diffusion coefﬁcient (Dsurf, i.e., DSDS or DDPC) is related to the micelle's
dimensions by the Stokes–Einstein relation:
RH ¼ kBT= 6πηDsurfð Þ
where RH is the hydrodynamic radius and η is the viscosity of the
aqueous medium. The RH values reported in Table 1 show that C8
caused a relevant increase in the dimensions of SDSmicellar aggregates.
3.2.3. Spin-label studies
To investigate the positioning of the peptide with respect to the
surface of the micelles, 5-doxyl-stearic acid paramagnetic probes
were used. 5-Doxyl-stearic acid contains a doxyl head group, a cyclic
nitroxide with an unpaired electron, that is bound to the aliphatic
chain carbon at position 5. Unpaired electrons lead to dramatically
accelerated longitudinal and transverse relaxation rates of protons in
spatial proximity via highly efﬁcient spin-electron relaxation. Paramag-
netic probes are known to induce broadening of the NMR signals and
decreases in the resonance intensities of residues close to the surface
(5-doxyl) of the micelles [72–75].
TOCSY spectra of C8 in the presence and absence of the spin labels
were recorded, keeping all other conditions the same. In the presence
of 5-doxyl stearic acid, several NH/CHα signals from the experiments
performed in the presence of the spin label were broadened and
decreased in intensity relative to those for a control sample without
the spin label. Graph shown in Fig. 5 presents the variation in theNH in-
tensities measured for C8 in micelle solutions with or without 5-doxyl
stearic acid. In DPC micelles, an evident effect of the spin label was
observed, with a drastic reduction in the NH intensities, particularly
those for Trp1, Glu2, Trp4 and Trp5. In SDSmicelles, a moderate and non-
speciﬁc reduction in the NH intensity was evident, with Gly6 and Ile8
exhibiting signiﬁcant perturbations.
3.3. Molecular dynamics simulations
MD simulations of C8 with DPC and SDS micelles at pH 7 were per-
formed to examine the peptide/micelle interactions at the atomic level.
The NMR structures solved for the SDS and DPC micelle solutions
were used as the starting conformations, and the initial position of
the peptide was determined according to the two protocols described
in the Experimental section. In all cases, similar initial conﬁgurations
were observed: the peptide comes into close contact with the micelle
head groups within the ﬁrst few nanoseconds and equilibrates for the
rest of the simulation (up to 50 ns). The ﬂuctuations in the temperature,
pressure, density and total energy (potential + kinetic) of the systems
at the minimal values were recorded. The backbone root-mean-square
deviation (RMSD) values from the initial secondary structures of C8 as a
function of time show that the peptide formed transient secondary struc-
tures ranging from turn-helix to turn conformations (Supplementary
data).
The analysis of the trajectories for C8 in SDS micelles showed that
during the ﬁrst 40 ns of the simulation, C8, which was surrounded by
water molecules (10–14 water molecules within 4 Å of the peptide)
and two Na+ ions, binds SDS, inducing changes to the micelle's surface
and shape. After 40 ns, thepeptide–micelle systemundergoes a structur-
al reorganization and changes morphology due to the loss of three SDS
molecules and several water molecules. RDF graphs (Supplementary
data) showing the radial distribution functions (g(r)) for the backboneNHs of the peptide and the C-12 atom of the SDS molecules indicate
that C8 is in contact with the inner core of the detergent as a conse-
quence of the destabilization of the micelles (Fig. 6).
In contrast to the SDS micelles, the DPC micelles were not modiﬁed
upon interaction with the C8 peptide according to the analysis of the
trajectory. Both the number of DPCmolecules and the spherical symme-
try were preserved. C8 interacts strongly with the DPC micelle surface,
as demonstrated by the RDF values involving the C8 backbone NHs
and the phosphate head groups of DPC (Supplementary data). This in-
teraction has a stabilizing effect, as indicated by the free binding energy
of 8.8 kcal/mol. The interaction with DPC micelles involves primarily
Trp residues at the expense of the peptide's secondary structure,
which is moderately altered to permit the best interactions with the
Trp side chains. The peptide remains on the micelle surface, where it
maintains greater ﬂexibility and, on average, lower potential energies
as compared to C8 in SDS micelles.
Fig. 6. Binding poses of the fusogenic peptide C8 on DPC and SDS micelles as derived from molecular dynamics calculation of C8 in the micelle–water system. Molecular dynamics
simulations were performed using YASARA 12.7.1650, using YAMBER3 force ﬁeld.
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C8 (Ac-Trp-Glu-Asp-Trp-Val-Gly-Trp-Ile-NH2), a tryptophan-rich
octapeptide modeled on the MPER of gp36 in FIV, exhibits antiviral
activity both in vitro and in vivo, resulting from the blocking of the
cell entry. The antiviral activity of C8 is related to its tendency to stably
reside at membrane interfaces, leading to the destabilization of the
bilayer structure [16,17].
To facilitate the design of new molecules able to inhibit virus cell
entry that are modeled on the C8 peptide and target FIV MPER, we con-
sidered it extremely important to investigate the behavior of C8 at the
membrane level. Accordingly, using combined approaches based on
ﬂuorescence and EPR spectroscopy, neutron diffraction and molecular
dynamics simulation, we have analyzed the ability of C8 to interact
with membrane models composed of zwitterionic POPC and DMPC
phospholipids [26]. In addition, very recently [29] we investigated on
the importance of cholesterol and sphingomyelin in regulating the
interaction of the fusogenic peptide C8 with DPPC bilayers. Based on
the evidence that the lipid composition is a key factor that ﬁne tunes
the physicochemical properties of the membrane [76], contributing to
the fusogenic activity of viral proteins [77,78], our previous studies ex-
plored the structural behavior of C8 in different bio-membrane systems.
These membrane models, although complex and highly bio-mimetic,
offered only indirect information about C8's conformational behavior
at the membrane level.
High resolution NMR spectroscopy is a suitable method to have the
structural coordinates of C8 in membrane mimetic environments, how-
ever for a high resolution NMR analysis, membrane mimicking systems
are required that tumble sufﬁciently quickly to produce sharp NMR
spectral lines [30,31]. Micelle and bicelle solutions are suitable for
these experimental purposes. In particular of the two systems, bicelles
have been shown to be better mimics of biological membranes, but
may form poor stable solutions and are expensive in the deuterated
form.Micelles deﬁne an evenmore simpliﬁedmodel of biologicalmem-
brane as compared to bicelles and their use is questioned especially due
to the curvature of the aggregates. On the contrary they have economic
advantages in comparison to bicelles and form stable solution ease
to use [79–82]. Based on the reported considerations and in view of
the extended exploration of conformational conditions, we decided to
use micellar solutions to analyze the conformation of C8. CD and NMR
experiments in SDS and DPC micelle solutions chosen as models of
negatively charged and zwitterionic membranes, allowed the determi-
nation of structural coordinates. Additionally the positioning of C8 on
the micelles' surfaces was investigated by collecting Trp ﬂuorescence
spectra, PFG-NMR spectra and spin label-aided NMR measurements.The NMR and CD experiments showed that C8 undergoes to a
conformational transition from a random coil to a turn-helical confor-
mation (Fig. 1)whenmoving fromphosphate buffer tomicellar concen-
trations of the zwitterionic surfactant DPC. 3D models calculated on
the basis of the NMR data in DPC micelles point to the presence of
type I β-turns involving Trp1–Trp4, Glu2–Val5 and Val5–Ile8, with an
ordered orientation of the amino acid side chains. Interestingly, the
indolyl rings of Trp1 and Trp4 deﬁne a hydrophobic envelope that inter-
actswith the surface of the zwitterionic DPCmicelle, as evident from the
Trp ﬂuorescence curves, which show abrupt shifts when DPC micelles
are formed (Fig. 4). A selective but evident decrease in the signal inten-
sities induced by 5-doxyl stearic acid (Fig. 5) led to the deﬁnition of a
map of interactions between C8 and the zwitterionic micellar surface.
The evident decrease in the intensities of the backbone NHs belonging
to residues Trp1, Glu2, Trp4 and Val5 shown in Fig. 5 suggests their
close proximity to the surface of the micelle. Shallow interactions are
evident for the C-terminal residues which appear only weakly suscepti-
ble to the presence of the spin labels. These data are in agreement with
the results ofmolecular dynamics simulation obtained inmicelle–water
system, and point to a structural behavior of C8 similar to that observed
in zwitterionic DPPC- or DOPC-bilayers [26].
The NMR data demonstrated conformational ﬂexibility for C8 in the
presence of negatively charged SDS micelles. The hydrophobic surface
of C8 is less compact in this medium, with the Trp indolyl rings assum-
ingmultiple different orientations (Fig. 3). The Trp ﬂuorescence of C8 is
imperceptibly affected by SDSmicelle formation, indicating the modest
exposure of Trp residues to the SDS micelle surface. Consistent with
these results, a weak perturbation of the signal intensities was observed
in the NMR spectra of C8 acquired in SDS micelles containing 5-doxyl
spin labels. The ﬂuorescence data and NMR spectra in the presence of
spin labels suggest that there is minimal interaction between C8 and
SDSmicelles. In contrast to the reported evidence, NMRdiffusion exper-
iments indicated that C8 diffuses togetherwith SDSmicelles and that C8
binding is able to modify SDS aggregates in terms of shape and dimen-
sions. The molecular dynamics simulation of C8 in a water–SDS micelle
system allowed the interpretation of these ambiguous results: in the
molecular dynamics simulation of C8 in a water–micelle system, the
binding of C8 to the SDSmicelle surface surrounded bywatermolecules
is a statistically relevant event. C8, which is hydrated and ﬂexible,
induces change to the size and shape of the SDS aggregates, leading to
the occasional loss of tensioactive molecules.
The interactions between membrane-active peptides and the mem-
brane surface are primarily mediated by hydrophobic and electrostatic
effects [83,84]. C8, having three Trp residues, is highly favored in hydro-
phobic interactions with phospholipid molecules of membrane surface.
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residues; therefore, the tendency of C8 to interact with hydrophobic
membranes may be limited due to the electrostatic repulsion between
the negative side chains of C8 and the negative sulfate heads of SDS.
Two primary driving forces control the interaction between C8 and
negatively charged membrane surfaces: the strong hydrophobic inter-
action due to the three Trp residues and the electrostatic repulsion
due to the negatively charged Asp and Glu residues. Our data suggest
that to mitigate electrostatic repulsion the peptide surrounds itself
with water molecules. The presence of water envelope is demonstrated
by i) the ﬂuorescence data showing that Trp is exposed to an aqueous
environment and ii) the weak perturbation of the NH NMR signals by
the spin labels. Both the diffusion experiments and the molecular
dynamics simulations indicate that interaction of C8 with the SDS
micelle surface, mediated by water, induces the destabilization of the
aggregates, with changes to their shape and dimensions.
Considering the membrane fusion activity of the C8 peptide and its
possible analogs and considering the compositions of the virus and
cell membranes, characterized by a relevant content of negative charge,
our data open the question of which type of structural behavior of a
fusion peptide is the most appropriate to obtain membrane fusion.
This in turn leads to the question ofwhich conditionwe should consider
for the design of new fusion inhibitors, either (i) the condition charac-
terized by the stable positioning of the peptide on the membrane's
surface through hydrophobic interactions or (ii) the more ﬂuid condi-
tion in which the peptide hydrated and ﬂexible, interacts in disordered
mode with the membrane to induce destabilization. The evaluation of
the structural behavior of fusion peptides onmembranes with different
compositions is in progress to answer this question.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.12.010.
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